NCT05857176

Brief Summary

This is a cross-sectional, web-based online survey done with the use of a Google Form-questionnaire to gather information from the general public regarding their knowledge, satisfaction, and tolerability about the COVID-19 vaccine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
508

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

May 10, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 12, 2023

Completed
Last Updated

May 23, 2023

Status Verified

May 1, 2023

Enrollment Period

2 months

First QC Date

May 10, 2023

Last Update Submit

May 21, 2023

Conditions

COVID-19 Vaccine Adverse Reaction

Outcome Measures

Primary Outcomes (4)

  • headache incidence

    Pecentage

    3 month

  • fever incidence

    Pecentage

    3 month

  • fatigue incidence

    Pecentage

    3 month

  • pain at site of injection incidence

    Pecentage

    3 month

Interventions

COVID-19 Vaccine questionnaireOTHER

An online questionnaire, designed on Google Forms, was written in Arabic language and delivered to participants via social media (primarily Facebook, WhatsApp and Linkedin).

Also known as: Google form questionnaire

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The subjects participating in the study are residents in Egypt who complete the online questionnaire.

You may qualify if:

  • all adults (age ≥ 18 years) complete the questionnaire were considered eligible to participate in the survey.

You may not qualify if:

  • Incomplete questionnaires were excluded from the final analysis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehab Hussein Werida

Damanhūr, Elbehairah, 31527, Egypt

Location

Related Publications (2)

  • Malik A, Malik J, Ishaq U. Acceptance of COVID-19 vaccine in Pakistan among health care workers. PLoS One. 2021 Sep 15;16(9):e0257237. doi: 10.1371/journal.pone.0257237. eCollection 2021.

    PMID: 34525110BACKGROUND

  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20.

    PMID: 33082575BACKGROUND

Study Officials

  • Rehab H Werida, Ass. Prof.

    Damanhour University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 10, 2023

First Posted

May 12, 2023

Study Start

December 15, 2021

Primary Completion

February 1, 2022

Study Completion

February 10, 2022

Last Updated

May 23, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)